Calcium channel blockers and Alzheimer's disease
Neural Regeneration Research, ISSN: 1876-7958, Vol: 7, Issue: 2, Page: 137-140
2012
- 22Citations
- 51Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations22
- Citation Indexes22
- 22
- Captures51
- Readers51
- 51
Article Description
Alzheimer's disease is characterized by two pathological hallmarks: amyloid plaques and neurofibrillary tangles. In addition, calcium homeostasis is disrupted in the course of human aging. Recent research shows that dense plaques can cause functional alteration of calcium signals in mice with Alzheimer's disease. Calcium channel blockers are effective therapeutics for treating Alzheimer's disease. This review provides an overview of the current research of calcium channel blockers involved in Alzheimer's disease therapy.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84856458371&origin=inward; http://dx.doi.org/10.3969/j.issn.1673-5374.2012.02.010; http://www.ncbi.nlm.nih.gov/pubmed/25767489; https://dx.doi.org/10.3969/j.issn.1673-5374.2012.02.010; https://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zgsjzsyj-e201202010; http://sciencechina.cn/gw.jsp?action=cited_outline.jsp&type=1&id=4439042&internal_id=4439042&from=elsevier
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know